Clinical Trials Directory

Trials / Completed

CompletedNCT00743119

Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
34 (actual)
Sponsor
New York State Psychiatric Institute · Academic / Other
Sex
Female
Age
21 Years – 45 Years
Healthy volunteers
Accepted

Summary

The following study is designed to determine the analgesic efficacy of smoked marijuana (0, 1.98, and 3.56% THC) and oral THC (0, 10, and 20 mg) in the Cold-Pressor Test (CPT), a laboratory model of pain which has predictive validity for clinical use of analgesics. Oral THC (dronabinol) is known to have a slower onset and longer duration of action compared with smoked marijuana. Therefore, the analgesic effects of oral THC is expected to peak later and last longer than effects produced by smoked marijuana.

Detailed description

Laboratory animal studies have demonstrated the analgesic effects of drugs which act on the cannabinoid system, however, these effects have et to be clearly elucidated in humans. To better understand the potential clinical application of cannabinoids for pain management, the following study is designed to determine the analgesic efficacy of smoked marijuana (3.56% THC) and oral THC (20 mg) in the Cold-Pressor Test (CPT), a laboratory model of pain which has predictive validity for clinical use of analgesics. Non-treatment seeking marijuana smokers will be recruited for a five-session study during which the analgesic, subjective, and physiologic effects of cannabinoids will be evaluated. Determining the efficacy of cannabinoids in an experimental model of pain will provide important endpoints (i.e., dose, route of administration, time course) or this effect to further investigate the potential role for clinical use of smoked marijuana and/or oral THC as analgesics.

Conditions

Interventions

TypeNameDescription
DRUGPlacebo capsulesPlacebo capsules
DRUGInactive marijuana (0% THC)Inactive marijuana cigarettes (0% THC) provided by NIDA
DRUGLow dose DronabinolDronabinol 10mg
DRUGHigh dose DronabinolDronabinol 20mg
DRUGLow THC marijuanamarijuana cigarettes (1.98% THC) provided by NIDA
DRUGHigh THC marijuanaMarijuana cigarettes (3.56% THC) provided by NIDA

Timeline

Start date
2008-06-01
Primary completion
2009-10-01
Completion
2013-05-01
First posted
2008-08-28
Last updated
2017-12-11
Results posted
2017-12-11

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT00743119. Inclusion in this directory is not an endorsement.